IP Library Granted Patent US 6,906,080
Granted Patent B1
US 6,906,080 · App. 10/111,765 · Granted Jun 14, 2005

Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,906,080
App. No.
10/111,765
Granted
Jun 14, 2005
Kind
B1
Abstract

The subject of the invention is tricyclic derivatives of pyrazolecarboxylic acid of formula: in which R 1 represents a C 3 -C 15 carboxyl radical or an NR 2 R 3 group. The invention also relates to the method for preparing the compounds of formula (I), pharmaceutical compositions containing them. The compounds of formula (I) are active on cannabinoid CB 1 receptors.

Claims (19)

1. A compound of formula:

in which:

X—Y— represents —CH 2 —S(O) p — or —S(O) p —CH 2 —;

n is equal to 1 or 2;

p is equal to zero, 1 or 2;

g 2 , g 3 , g 4 , g 5 , w 2 , w 3 , w 4 , w 5 , w 6 are identical or different and each independently represent hydrogen, a halogen, a trifluoromethyl, a (C 1 -C 4 )alkyl, a (C 1 -C 4 )alkoxy, a (C 1 -C 4 )alkylthio, a nitro; at least one of the substituents w 2 , w 3 , w 4 , w 5 , w 6 being different from hydrogen;

R 1 represents an NR 2 R 3 group;

R 2 and R 3 each separately represent hydrogen or a (C 1 -C 6 )alkyl, or R 2 or R 3 , together with the nitrogen atom to which they are attached, constitute a saturated or unsaturated 5- to 10-membered heterocyclic radical which is unsubstituted or substituted one or several times with a (C 1 -C 4 )alkyl;

or a pharmaceutically acceptable salt or solvate thereof.

2. The compound as claimed in claim 1 , in which g 2 , g 3 , g 5 , w 3 , w 5 , w 6 represent hydrogen and g 4 , w 2 and w 4 have one of the values defined above for the compounds of formula (I) except hydrogen.

3. The compound as claimed in claim 2 , in which w 2 and w 4 represent chlorine and g 4 represents chlorine or bromine.

4. A compound as claimed in claim 3 , in which R 1 represents NR 2 R 3 , R 2 and R 3 constituting, with the nitrogen atom to which they are attached, a saturated 5- to 10-membered heterocyclic radical which is unsubstituted or substituted one or several times with a (C 1 -C 4 )alkyl.

5. A compound as claimed claim 4 , in which X—Y represents —CH 2 —S—.

6. A pharmaceutical composition containing a compound as claimed in claim 1 .

7. The pharmaceutical composition as claimed in claim 6 , in the form of a dosage unit.

8. A pharmaceutical composition containing a compound as claimed in claim 2 .

9. A pharmaceutical composition containing a compound as claimed in claim 3 .

10. A pharmaceutical composition containing a compound as claimed in claim 4 .

11. A pharmaceutical composition containing a compound as claimed in claim 5 .

Assignments (3)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
CHANGE OF NAME Recorded Apr 25, 2005
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 015941/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2002
From: BARTH, FRANCIS; CONGY, CHRISTIAN; MARTINEZ, SERGE; RINALDI, MURIELLE
To: SANOFI-SYNTHELABO
Reel/Frame 013140/0685 →